Latest Breaking News On - Chairman satish reddy - Page 1 : comparemela.com

Updated: MRP of each sachet ₹990, to be offered at subsidised rate to govt institutions Share Article AAA An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by INMAS, a lab of DRDO, in collaboration with Dr Reddy’s Laboratories, Hyderabad. The drug will help in faster recovery of Covid-19 patients. Twitter/@DRDO India   MRP of each sachet ₹990, to be offered at subsidised rate to govt institutions Drugmaker Dr. Reddy’s Laboratories has announced the commercial launch of 2-deoxy-D-glucose (2-DG), an oral drug for use as an adjunct therapy for hospitalised COVID-19 patients. The maximum retail price is ₹990 per sachet. It will be made available at a subsidised rate to government institutions, the company said, adding its 2-DG has a purity of 99.5%.

Andhra pradeshG satheesh reddySatish reddyInstitute of nuclear medicine allied sciencesNuclear medicineAllied sciencesChairman satish reddyஆந்திரா பிரதேஷ்க் சதீஷ் சிவப்புசத்தீஷ் சிவப்புநிறுவனம் ஆஃப் அணு மருந்து கூட்டணி அறிவியல்அணு மருந்துகூட்டணி அறிவியல்தலைவர் சத்தீஷ் சிவப்பு